Arko Sen

Noncoding regulatory mutations contribute to the aberrant gene expression profile of neuroblastomas

Comprehensive analyses of whole-genome and exome sequencing data from high-risk neuroblastoma tumors have identified relatively few recurrent and clinically actionable protein-coding driver mutations at initial diagnosis. This suggests that noncoding genetic variations that alter regulatory sequences and impact gene ex...